Schizoaffective Disorders Completed Phase 1 Trials for Olanzapine (DB00334)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00094640Pharmacokinetic Characterization of Intramuscular Olanzapine DepotTreatment
NCT00287352Study of Amantadine for Weight Stabilization During Olanzapine TreatmentTreatment